These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2483 related items for PubMed ID: 17611117

  • 1. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

  • 2. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [Abstract] [Full Text] [Related]

  • 3. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [Abstract] [Full Text] [Related]

  • 4. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 5. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Feb; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 6. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2004 Feb; 24(3b):1953-6. PubMed ID: 15274383
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S.
    Ann Thorac Surg; 2007 Jan; 83(1):216-21. PubMed ID: 17184666
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H.
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
    [Abstract] [Full Text] [Related]

  • 9. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS.
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [Abstract] [Full Text] [Related]

  • 10. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
    Cedrés S, Nuñez I, Longo M, Martinez P, Checa E, Torrejón D, Felip E.
    Clin Lung Cancer; 2011 May; 12(3):172-9. PubMed ID: 21663860
    [Abstract] [Full Text] [Related]

  • 11. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
    Suzuki H, Ishikawa S, Satoh H, Ishikawa H, Sakai M, Yamamoto T, Onizuka M, Sakakibara Y.
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.
    Anticancer Res; 2000 Oct; 20(3B):2177-80. PubMed ID: 10928173
    [Abstract] [Full Text] [Related]

  • 13. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T, Fetz TH, Dienemann H, Hoffmann H, Herth FJ, Meister M, Ebert W.
    Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
    [Abstract] [Full Text] [Related]

  • 14. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 Jun; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 15. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
    Li L, Song LH, Ding SC, Zhang XJ, Qiang L, Han CY, Yuan XT, Xu DD.
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):850-4. PubMed ID: 21223692
    [Abstract] [Full Text] [Related]

  • 16. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S, Shen L, Qian N, Chen K.
    Cancer Biomark; 2010 Nov; 10(3-4):155-62. PubMed ID: 22674301
    [Abstract] [Full Text] [Related]

  • 17. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M.
    Cancer; 2006 Dec 15; 107(12):2842-9. PubMed ID: 17103443
    [Abstract] [Full Text] [Related]

  • 18. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
    Zhang ZF, Ma JQ, Sun N, Zhang L.
    Zhonghua Wai Ke Za Zhi; 2004 Jul 07; 42(13):817-9. PubMed ID: 15363304
    [Abstract] [Full Text] [Related]

  • 19. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 07; 39(5):832-5. PubMed ID: 19024326
    [Abstract] [Full Text] [Related]

  • 20. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS, Zhang DC, Zhao XH, Wang LJ, Qi J, Li XX.
    Zhonghua Zhong Liu Za Zhi; 2003 Sep 07; 25(5):457-60. PubMed ID: 14575569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 125.